Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Anastrozole (Primary) ; Pazopanib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 29 Mar 2017 Status changed to discontinued due to slow accrual
- 24 May 2016 Status changed from discontinued to completed.